Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy 
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission 
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 
Tabletop particle accelerator could transform medicine and materials science 
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now 
NASA Partners with Katalyst to Save Swift Observatory with Innovative Docking Mission 
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets 
SpaceX Starship Test Flight Reaches New Heights but Ends in Setback 
Ancient Mars may have had a carbon cycle − a new study suggests the red planet may have once been warmer, wetter and more favorable for life 
Neuralink Expands Brain Implant Trials with 12 Global Patients 
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 
Since its outbreak in December of 2019, the COVID-19 pandemic has affected millions of people all over the world. As cases of the coronavirus rise in many countries, scientists have shown images happening in real-time on how the virus attacks the cells in the human body.
Express reports real-time images were shown of how the coronavirus SARS-CoV2 attacks humans. From the images, it shows a spike protein on the coronavirus functioning as the main weapon to mobilize the DNA into a host cell. The virus then attacks and sticks into the ACE 2 enzyme, becoming an important process in how the virus is spread. The ACE 2 enzyme receptors are what enable the attack by the virus.
Scientists from the Naval Research Laboratory, the team of Kiril Gorshkov and Eunkeu Oh were able to image this process. They also used this same imaging process for cancers, lysosomal storage diseases, and other viral diseases. “You can actually see that happen in real-time. That’s the beauty of this essay and that’s why we think it will be important for drug screening,” said Dr. Gorshkov.
As the months go by, scientists are scrambling to speed up research and develop a vaccine that could help treat COVID-19 patients and prevent others from contracting the virus. As a result, to at least slow down the spread, social distancing practices and quarantine periods are put in place by the respective governments in countries that are affected. Face masks are also required to be worn in places where social distancing could not be maintained.
Schools have also resorted to online or remote learning but there are some educational institutions that have reopened to allow for in-person learning. However, as there are several months left until the Christmas season, an expert has warned not to anticipate that a vaccine would be available by that time.
UK Health Secretary Matt Hancock commented on what is known as the Oxford vaccine, that is produced by the UK pharmaceutical firm AstraZenica and is currently on its phase three trials with over 50,000 volunteers spanning in different countries. “The best-case scenario is that happens this year. I think more likely is the early part of next year -- in the first few months of next year is the most likely,” said Hancock.
